CAREER
People
ON THE MOVE Insight's monthly bulletin to keep the Australian ophthalmic sector updated on new appointments and personnel changes, nationally and globally.
KYLEE HALL PROMOTED TO THE HELM OF CYLITE Cylite’s former Vice President of Sales and Marketing, Ms Kylee Hall, has taken over as CEO from the company’s Founder and Director, Dr Steve Frisken. Frisken will continue in an executive leadership role to provide operational and innovation guidance to the company. Previously Manager of Zeiss Australasia’s Medical Division, Hall took time away from the profession to pursue an Executive MBA, before joining Cylite in February 2020. “With over $25 million in private and government investment to date and a solid roadmap for the future, I am looking forward to establishing Cylite as world leader in digital health,” she said.
GLAUCOMA AUSTRALIA SEEKS NEXT CEO Glaucoma Australia CEO Ms Annie Gibbins is leaving the organisation after four and a half years. Gibbins, first appointed in 2018, came to the role with an agenda to reform and modernise the organisation, overseeing a dramatic rise in referrals and integration with Oculo platform. She has helped GA drive greater risk awareness and improve treatment adherence. Gibbins will now spend more time on her other passion empowering women to achieve business success. She also hopes to spend more time with her grandchildren and perform admin work for the Australasian College of Optical Dispensing, operated by husband Mr James Gibbins.
OPTOMETRIST CONTINUES IMPORTANT DIABETES WORK Primary Care Diabetes Society of Australia (PCDSA) has welcomed Dr Amira Howari as its newest Board Member. Having type one diabetes for almost 30 years, Howari arrives with her lived and clinical experience as a senior clinical optometrist specialising in diabetes, working in interdisciplinary primary care settings. She has taken up several roles including Diabetes Australia Ambassador, Member of the Diabetes and Endocrine Network at the agency of Clinical Innovation (NSW Health), a UNSW Guest Speaker and Clinical Supervisor and former Optometry Australia Board Councillor (NSW/ACT).
AUSSIE FIRM OPTHEA APPOINTS NEW CHIEF MEDICAL OFFICER Melbourne biopharmaceutical company Opthea has made Dr Joel Naor its new Chief Medical Officer. California-based Naor is an ophthalmologist and has over two decades of experience leading clinical development programs that target retinal conditions. Most recently, he served as Vice President of Clinical Science and Development Operations at Kodiak Sciences Inc. Previously, he was the Chief Medical Officer for Macusight until it was acquired by Santen in 2010, and subsequently served as Vice President and Head of Global Medical Affairs for Santen.
ESSILORLUXOTTICA REVEALS NEW HEAD OF ANZ WHOLESALE BUSINESS Experienced Essilor business leader Mr Marco Caccini has been appointed to lead the new EssilorLuxottica Wholesale Business for Australia and New Zealand. Caccini assumes the role that will see Mr Stephen Locke, Luxottica’s Country Manager of Wholesale ANZ, and Mr Pierre Longerna, Essilor’s ANZ Country Manager, now reporting directly to him. Caccini joined Essilor, now EssilorLuxottica, in 2000 as Director of the US Supply Chain before taking on more responsibility in the US and Europe in strategic, commercial, and operational roles.
NOVA EYE MEDICAL BOSS JOINS GLAUCOMA ADVISORY BOARD Nova Eye Medical President Mr Joe Bankovich has been appointed as an Industry Representative to the American Glaucoma Society Foundation Advisory Board. Established in 2011 with more than 1,500 members, the foundation runs programs to support glaucoma research and education. It also provides a platform for physicians, researchers and the US Food and Drug Administration (FDA) to collaborate in the development of the regulatory science that guides the approval of new glaucoma diagnostic technologies and surgical devices.
Do you have career news to share? Email editor Myles Hume at myles.hume@primecreative.com.au to be featured. 56
INSIGHT May 2022
